Numinus Wellness Inc. Stock Toronto S.E.
Equities
NUMI
CA67054W1032
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0500 CAD | -.--% |
|
-.--% | - |
| Capitalization | 19.82M 14.42M 12.4M 11.35M 10.72M 1.39B 20.14M 135M 52.65M 657M 54.11M 52.97M 2.29B | P/E ratio 2023 |
-1.72x | P/E ratio 2024 | -0.48x |
|---|---|---|---|---|---|
| Enterprise value | 19.89M 14.47M 12.45M 11.39M 10.76M 1.4B 20.21M 135M 52.85M 660M 54.31M 53.16M 2.3B | EV / Sales 2023 |
2.21x | EV / Sales 2024 | 2.48x |
| Free-Float |
98.26% | Yield 2023 * |
-
| Yield 2024 | - |
| 3 years | 0.02 | 0.28 | |
| 5 years | 0.02 | 1.18 | |
| 10 years | 0.02 | 2.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Tan
CEO | Chief Executive Officer | - | 2025-01-22 |
Kelvin Yang
DFI | Director of Finance/CFO | - | 2025-02-17 |
Paul Thielking
CTO | Chief Tech/Sci/R&D Officer | - | 2022-06-09 |
| Director | Title | Age | Since |
|---|---|---|---|
Payton Nyquvest
CHM | Chairman | - | 1962-06-25 |
Michael Tan
BRD | Director/Board Member | - | 2020-05-14 |
Larry Timlick
BRD | Director/Board Member | 69 | 2019-01-27 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 11.25M | ||
| +0.92% | +3.86% | -12.71% | -14.79% | 43.7B | ||
| +3.95% | -2.47% | +30.35% | +32.73% | 34.32B | ||
| +2.06% | +0.26% | +271.46% | +481.55% | 31.96B | ||
| -0.97% | -0.51% | +18.32% | -14.01% | 28.62B | ||
| -1.70% | -5.83% | +20.14% | +12.65% | 25.12B | ||
| +1.41% | -0.92% | - | - | 14.99B | ||
| +1.44% | +0.26% | +131.52% | +4,144.54% | 13.54B | ||
| +1.34% | +5.61% | +9.14% | +2.71% | 12.71B | ||
| +1.65% | -3.27% | +117.75% | +91.53% | 12.4B | ||
| Average | +1.01% | -0.58% | +73.25% | +592.11% | 24.15B | |
| Weighted average by Cap. | +1.15% | -0.48% | +66.95% | +361.14% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 23.18M 16.87M 14.5M 13.28M 12.54M 1.63B 23.55M 157M 61.59M 769M 63.29M 61.96M 2.68B | 4.17M 3.03M 2.61M 2.39M 2.26M 293M 4.24M 28.31M 11.08M 138M 11.38M 11.14M 482M |
| Net income | -30.26M -22.02M -18.93M -17.33M -16.37M -2.13B -30.74M -205M -80.39M -1B -82.61M -80.87M -3.5B | -19.64M -14.29M -12.29M -11.25M -10.63M -1.38B -19.96M -133M -52.19M -652M -53.63M -52.5M -2.27B |
| Net Debt | -1.38M -1M -864K -791K -747K -97M -1.4M -9.37M -3.67M -45.79M -3.77M -3.69M -159M | 74.32K 54.07K 46.5K 42.57K 40.22K 5.22M 75.51K 505K 197K 2.47M 203K 199K 8.59M |
Employees
-
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NUMI.F Stock
- NUMI Stock
Select your edition
All financial news and data tailored to specific country editions
















